查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1247437

2023-2030 年胸骨閉合系統的全球市場

Global Sternal Closure Systems Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

胸骨閉合系統的全球市場規模預計到 2022 年將達到 22.9525 億美元，到 2030 年將達到 34.4626 億美元，在預測期間（2023-2030 年）的複合年增長率為 5.3%。

胸骨閉合系統是一種醫療器械，用於在中央胸骨切開術後閉合胸骨（胸骨），這是一種將胸骨分開以進入胸腔的外科手術。

這些系統通常由金屬板、金屬絲和縫合線組成，用於將分離的胸骨兩半牢固地固定到位。 傷口閉合系統的目的是在癒合過程中為胸骨提供穩定性和支撐，以防止感染、傷口脫落和胸部不穩定等並發症。

市場動態

全球胸骨閉合系統市場的增長受到技術進步的推動，技術進步導致心臟和胸外科手術的發生率增加、人們越來越意識到胸骨閉合的重要性、人口老齡化以及醫療保健成本上升。增加.

心髒病負擔的增加推動了市場增長

冠狀動脈旁路移植術和瓣膜置換術等心臟手術的興起增加了對胸骨閉合系統的需求

。

在世界範圍內，心血管疾病 (CVD) 是導致死亡的主要原因。 心血管疾病，尤其是缺血性心髒病 (IHD) 和中風，是導致殘疾的主要原因。 由於其高患病率、死亡率、發病率和治療的經濟負擔，心力衰竭是一項重大的醫療保健挑戰。 到 2030 年，預計將有超過 800 萬美國人患有 HF。 HF 的頻率隨著年齡的增長而增加，從大約每 1,000 名 65 歲至 69 歲的人中有 20 人增加到每 1,000 名 85 歲及以上的人中超過 80 人。 心力衰竭最常見的原因是瓣膜性心髒病、高血壓和缺血性心髒病。

此外，風濕性心髒病 (RHD) 仍然是全球 VHD 的主要原因。 另一方面，退行性瓣膜病被認為是發達國家 VHD 最常見的病因。 VHD 的患病率從 45 歲以下人群的 0.7% 增加到 75 歲以上人群的 13%。 此外，CVD 影響了世界 50% 的人口（女性）。 到 2021 年，CVD 仍然是女性發病率和死亡率的主要原因，儘管過去幾十年心血管護理取得了重大進展。 城市化和生活方式的改變導致包括埃塞俄比亞在內的幾個非洲國家的心血管疾病 (CVD) 發病率和患病率增加，非洲人正在經歷快速的流行病學變化。

與胸骨閉合系統相關的風險阻礙了市場增長

但是，與胸骨閉合系統相關的風險是： 胸骨閉合系統會增加術後感染的風險，尤其是在切口未得到適當護理的情況下。 胸骨分離存在胸骨不穩定的風險，並可能導致疼痛、呼吸困難和其他並發症。 手術過程中可能會損傷神經，導致胸部和手臂麻木、麻木、無力。 設備故障可能導致斷線和其他問題，並有需要重複手術的風險。

COVID-19 影響分析

COVID-19 大流行將對胸骨閉合系統市場產生重大負面影響。 正如 2020 年發表在《國際外科雜誌》上的一篇文章，心胸外科將不可避免地受到 COVID-19 的影響。 在英國和美國，所有選擇性和非緊急手術都已推遲，資源將用於緊急和急診心胸科服務。 此外，心臟外科醫生具有可轉移到 ITU 的一般技能，使他們成為重新定位的理想人選。 NHS England 發布了基於 COVID-19 大流行階段的心胸外科管理指南。

在大流行期間，擇期心胸外科服務將大大減少。 鼓勵外科醫生使用電話和視頻會議限制面對面的預約，並延遲非緊急轉診和隨訪。

截至 2023 年，COVID-19 情況有所改善，所有患者都可以使用醫療設施。 此外，對心臟和胸外科手術的需求不斷增加正在推動全球市場的發展

。

內容

第 1 章市場方法論和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 患者人數增加
      • 手術次數增加
    • 抑制因素：
      • 與胸骨閉合相關的潛在風險
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • 市場上 COVID-19 的分析
    • 在 COVID-19 市場情景之前
    • 當前的 COVID-19 市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格和動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 結論

第 7 章按產品類型

  • 骨水泥
  • 關閉裝置
    • 胸部閉合線
    • 用於胸骨閉合的鋼板和螺釘
    • 胸口夾
    • 胸部閉合電纜

第 8 章程序

  • 正中胸骨切開術
  • Hemisiter 注意我
  • 雙側胸骨切開術

第9章材料

  • 不銹鋼
  • 聚醚醚酮 (PEEK)
  • 鈦
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 競爭場景
  • 公司股票分析
  • 產品類型基準
  • 主要發展和戰略

第12章公司簡介

  • Depuy Synthes（強生公司）
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Zimmer Biomet Holdings
  • KLS Martin Group
  • Acute Innovations
  • JACE Medical, LLC.
  • Stryker
  • Idear S.R.L
  • Praesidia SRL
  • Kinamed Incorporated
  • B. Braun

第13章 DataM

簡介目錄
Product Code: MD1456

Market Overview

The global sternal closure systems market size was valued at US$ 2,295.25 Million in 2022 and is estimated to reach US$ 3,446.26 Million by 2030, growing at a CAGR of 5.3% during the forecast period (2023-2030).

Sternal closure systems refer to medical devices used to close the sternum (breastbone) after a median sternotomy, a surgical procedure in which the sternum is split open for access to the thorax. These systems usually consist of metallic plates, wires, or sutures used to fasten the separated halves of the sternum securely. The goal of sternal closure systems is to provide stability and support to the sternum during the healing process to prevent complications such as infection, wound separation, or instability of the chest.

Market Dynamics

The global sternal closure systems market growth is driven by technological advancements increasing incidence of cardiac and thoracic surgeries, growing awareness about the importance of sternal closure, aging population, and rise in healthcare expenditure.

An increasing burden of cardiac disorders drives the market growth

The growing number of cardiac surgeries, such as coronary artery bypass grafting and valve replacements, drives the demand for sternal closure systems. Across the world, cardiovascular disease (CVD) is the leading cause of mortality. Cardiovascular diseases, principally ischemic heart disease (IHD) and stroke, are major contributors to disability. Because of the high prevalence, mortality, morbidity, and financial burden of treating heart failure (HF), it is a significant healthcare concern. It is anticipated that more than eight million Americans will have HF by 2030. From about 20 per 1,000 people aged 65 to 69 to more than 80 per 1,000 people aged 85 and older, the frequency of HF rises with age. The most frequent causes of HF are valvular heart disease, hypertension, and ischaemic heart disease.

In addition, Rheumatic heart disease (RHD) is still a leading etiologic factor in the development of VHD worldwide. In contrast, degenerative valve disease is likely the most common etiology of VHD in developed countries. The prevalence of VHD increases from 0.7 % in people<45 years to 13 % in people over 75 years. Moreover, CVD affects 50% of the world's population (women). Despite significant progress in cardiovascular care over the past several decades, in 2021, CVD remains the major cause of morbidity and mortality for women. Urbanization and lifestyle modifications are contributing to a rise in the incidence and prevalence of cardiovascular diseases (CVDs) across several African nations, including Ethiopia, as Africans experience a rapid epidemiological transformation.

The risk associated with sternal closure systems will hamper the growth of the market

However, the risks associated with sternal closure systems. Sternal closure systems can increase the risk of postoperative infections, particularly if the incision is not properly cared for. There is a risk of sternal instability, which can cause the chest bones to separate and lead to pain, difficulty breathing, and other complications. There is a risk of nerve damage during the procedure, which can result in numbness, tingling, or weakness in the chest or arms. There is a risk of the device malfunction, which can lead to broken wires or other issues that require revision surgery. There is a risk of allergic reactions to the materials used in the sternal closure system, such as metals or adhesives.

COVID-19 Impact Analysis

The COVID-19 pandemic has profound adverse effects on the sternal closure systems market. As per the article published in the International Journal of Surgery in 2020, cardiothoracic practice will be inevitably affected by COVID-19. All elective and non-urgent procedures have been postponed in the UK and the US, with resources being redirected to the emergency and urgent cardiothoracic service. Furthermore, cardiothoracic surgeons possess generic skills which are mostly transferable to ITU, making them prime candidates for redeployment. NHS England has issued guidance on managing cardiothoracic procedures based on the phase of the COVID-19 pandemic.

The elective cardiothoracic surgery service will be greatly reduced throughout the pandemic. Surgeons are encouraged to use telephone and video conferencing to limit face-to-face appointments and to delay non-urgent referrals and follow-ups. Cardiothoracic surgeons can greatly support the ITU service, and attempts should be made to make senior staff available for redeployment.

As of 2023, the COVID-19 situation is recovering, and all patients can access healthcare facilities. In addition, increasing demand for cardiac and thoracic surgeries drives the market worldwide.

Segment Analysis

The closure devices segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)

The closure devices segment accounts for the highest market share. Sternal closure devices are used in cardiac surgery to securely close the sternum after a median sternotomy (an incision made down the center of the breastbone). The devices are designed to reduce the time required for sternal healing, minimize wound complications, and reduce patient discomfort compared to traditional wire cerclage methods. There has been increasing demand for sternal closure devices in recent years due to their benefits and technological advancements. Cardiac surgery procedures are becoming more prevalent due to an aging population and advancements in medical technology, leading to a growing demand for reliable and efficient sternal closure methods. Additionally, the benefits of faster recovery time and reduced patient discomfort associated with sternal closure devices have increased demand among patients and healthcare providers.

In addition, Medicon offers a titanium sternal closure system that allows stable internal fixation of the sternum after sternotomy or sternal fracture. Different titanium plates are available to suit the anatomical structures and individual clinical requirements. Also, Arthrex, Inc. offers A 100% nonmetallic, suture-based alternative to the conventional use of metal wires to bind the sternum after heart surgery, the FiberTape sternal closure system. Strong, repeatable compression from the FiberTape sternal closure implant, which is placed similarly to metal wires, aids in sternal approximation and stabilization.

Geographical Analysis

North America region holds the largest market share of the global sternal closure systems market

North America dominates the market for sternal closure systems and is expected to show a similar trend over the forecast period. Technological advancements, the rising prevalence of cardiac disease, and product launches by market players in the North American region drive the market.

As per the article published in the Journal of Thoracic Disease in 2022, In the U.S., thoracic surgeons can complete their training through various extremely competitive programs and are prepared to manage patients with chest problems during surgery and in the immediate aftermath. An average of 135 procedures are carried out by thoracic surgeons each year to treat conditions affecting the lungs, trachea, esophagus, chest wall, mediastinum, and diaphragm. The most frequent surgeries, usually done to treat lung cancer, are thoracoscopic surgeries with video assistance. With over 200,000 new cases anticipated this year, lung cancer is the deadliest and the second most common cancer in the U.S.

Additionally, the University of Michigan Medicine performs about 2,000 adult cardiac surgery procedures yearly using improving and cutting-edge therapies for heart and aortic illnesses.

Competitive Landscape

The sternal closure systems market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Depuy Synthes (Johnson & Johnson), Zimmer Biomet Holdings, KLS Martin Group, Acute Innovations, JACE Medical, LLC., Stryker, Idear S.R.L, Praesidia SRL, Kinamed Incorporated, and B. Braun, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the sternal closure systems market globally.

For instance,

  • In December 2020, Zimmer Biomet Holdings, Inc., acquired the Stryker Corporation, a Vance Street Capital Portfolio Company, for $150 million in cash at closing and $100 million in cash payable in 2021. Zimmer Biomet has acquired Stryker and its complete product portfolio of sternal closure devices - including cable systems, sternal sutures, and rigid fixation - along with a range of single-use complimentary temporary pacing wire and surgical punch products.

Zimmer Biomet Holdings

Overview:

Zimmer Biomet is a medical device company founded in 1927 and headquartered in the U.S. Their innovations enable the treatment of disorders of, or injuries to, joints, bones, and supporting soft tissues. Together with healthcare professionals, a company helps millions of people to live better lives.

Product Portfolio:

SternaLock XP Rigid Fixation System: The SternaLock XP Sternal Closure System is implied for stabilizing and fixing fractures of the anterior chest wall for sternal reconstructive procedures for patients with normal and poor bone.

The global sternal closure systems market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise in the patient population
      • 4.1.1.2. The increase in the number of surgical procedures
    • 4.1.2. Restraints:
      • 4.1.2.1. Potential Risks Associated with Sternal Closure
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Bone cement*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 7.3. Closure devices
    • 7.3.1. Sternal closure wires
    • 7.3.2. Sternal closure plates and screws
    • 7.3.3. Sternal closure clips
    • 7.3.4. Sternal closure cables

8. By Procedure

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 8.1.2. Market Attractiveness Index, By Procedure
  • 8.2. Median Sternotomy*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. Hemisternotomy
  • 8.4. Bilateral Thoracosternotomy

9. By Material

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 9.1.2. Market Attractiveness Index, By Material
  • 9.2. Stainless Steel*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Polyether Ether Ketone (PEEK)
  • 9.4. Titanium
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Company Share Analysis
  • 11.3. Product Type Benchmarking
  • 11.4. Key Developments and Strategies

12. Company Profiles

  • 12.1. Depuy Synthes (Johnson & Johnson)*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Zimmer Biomet Holdings
  • 12.3. KLS Martin Group
  • 12.4. Acute Innovations
  • 12.5. JACE Medical, LLC.
  • 12.6. Stryker
  • 12.7. Idear S.R.L
  • 12.8. Praesidia SRL
  • 12.9. Kinamed Incorporated
  • 12.10. B. Braun

LIST NOT EXHAUSTIVE

13. Global Sternal Closure Systems Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us